# CSX Corp: Form 10-Q for the period ended Mar 31, 2017

- Company: [CSX Corp](/companies/csx.md) (CIK 277948)
- Form: 10-Q
- Filed: 2017-04-20
- Accepted by EDGAR: Apr 20, 2017, 11:14 ET
- Period: 2017-03-31
- Accession: 0000277948-17-000019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/277948/000027794817000019/csx03311710-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/277948/000027794817000019/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Operating income | 3 months, 2016-12-31 to 2017-03-31 | $712.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2016-12-31 to 2017-03-31 | $137.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-12-31 to 2017-03-31 | $220.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-12-31 to 2017-03-31 | $362.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-12-31 to 2017-03-31 | $0.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2016-12-31 to 2017-03-31 | $0.39 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2016-12-31 to 2017-03-31 | 929,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2016-12-31 to 2017-03-31 | $1.04bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2016-12-31 to 2017-03-31 | $441.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2016-12-31 to 2017-03-31 | $166.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2016-12-31 to 2017-03-31 | $258.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-03-31 | $930.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-03-31 | $2.66bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-03-31 | $35.71bn | us-gaap:Assets |
| Current liabilities | at 2017-03-31 | $2.28bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-03-31 | $24.04bn | us-gaap:Liabilities |
| Shareholders' equity | at 2017-03-31 | $11.67bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | at 2017-03-31 | 922,687,144 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 2,444 characters.

CSX purchases its own shares for two primary reasons: (1) to further its goals under its share repurchase program and (2) to fund the Company’s contribution required to be paid in CSX common stock under a 401(k) plan that covers certain union employees.

During the first quarters of 2017 and 2016, the Company repurchased approximately $258 million, or six million shares, and $249 million, or ten million shares, respectively under the $2 billion share repurchase program announced in April 2015. As of April 5, 2017, the Company had completed all share repurchases under this program.

On April 20, 2017, the Company announced a new $1 billion share repurchase program, which is expected to be completed over the next 12 months.

Management's assessment of market conditions and other factors guides the timing and volume of repurchases. Future share repurchases are expected to be funded by cash on hand, cash generated from operations and debt issuances. Shares are retired immediately upon repurchase. In accordance with the *Equity Topic* in the ASC, the excess of repurchase price over par value is recorded in retained earnings. Generally, retained earnings is only impacted by net earnings and dividends.

Share repurchase activity for the first quarter 2017 was as follows:

| First Quarter (a) | CSX Purchases of Equity Securities for the Quarter Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs |
| --- | ---: | ---: | ---: | ---: |
| Beginning Balance |  |  |  | $270,270,134 |
| January | 2,044,818 | $38.93 | 1,938,768 | 195,428,197 |
| February | 1,660,565 | 47.58 | 1,660,500 | 116,424,432 |
| March | 2,175,500 | 47.78 | 2,175,500 | 12,474,350 |
| Ending Balance | 5,880,883 | $44.65 | 5,774,768 | $12,474,350 |

*(a) First quarter 2017 consisted of the following fiscal periods: January (December 31, 2016 - January 27, 2017), February (January 28, 2017 - February 24, 2017), March (February 25, 2017 - March 31, 2017).*

*(b) The difference of 106,115 shares between the "Total Number of Shares Purchased" and the "Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs" for the quarter represents shares purchased to fund the Company's contribution to a 401(k) plan that covers certain union employees.*

## Market risk

As filed, 213 characters.

There have been no material changes in market risk from the information provided under Part II, Item 7A (Quantitative and Qualitative Disclosures about Market Risk) of CSX's most recent annual report on Form 10-K.

## Controls and procedures

As filed, 801 characters.

As of March 31, 2017, under the supervision and with the participation of CSX's Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), management has evaluated the effectiveness of the design and operation of the Company's disclosure controls and procedures. Based on that evaluation, the CEO and CFO concluded that, as of March 31, 2017, the Company's disclosure controls and procedures were effective at the reasonable assurance level in timely alerting them to material information required to be included in CSX's periodic SEC reports. There were no changes in the Company's internal controls over financial reporting during the first quarter of 2017 that have materially affected or are reasonably likely to materially affect the Company's internal control over financial reporting.

## Risk factors

As filed, 433 characters.

For information regarding factors that could affect the Company's results of operations, financial condition and liquidity, see the risk factors discussed under Part II, Item 7 (Management's Discussion and Analysis of Financial Condition and Results of Operations) of CSX's most recent annual report on Form 10-K. See also Part I, Item 2 (Forward-Looking Statements) of this quarterly report on Form 10-Q.

CSX Q1 2017 Form 10-Q p.38

Filed Apr 20, 2017.
Source: SEC EDGAR, the filing index for accession 0000277948-17-000019. Last ingested by Listed: Nov 4, 2026, 17:13 ET. No prices; not investment advice.
